<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="28562">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02093416</url>
  </required_header>
  <id_info>
    <org_study_id>PRO13010529</org_study_id>
    <nct_id>NCT02093416</nct_id>
  </id_info>
  <brief_title>Leptin Receptors in the Bariatric Surgical Population Within the University of Pittsburgh Medical System: A Cohort Study</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective cohort study evaluating the role of leptin receptors in the bariatric surgical
      population compared with non obese controls.  Additionally serum levels of leptin, ghrelin,
      motilin and PYY will be compared amongst the different BMI classes and a quality of life
      questionnaire  completed by all participants.

      The hypothesis is that obese individuals have lower leptin receptors in enterocytes which is
      partially responsible for the higher serum leptin levels without appropriate control of
      satiety.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>PCR test for Leptin Receptors</measure>
    <time_frame>1 week</time_frame>
    <safety_issue>No</safety_issue>
    <description>Endoscopic biopsies of enterocytes will be measured via PCR</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ELISA test for ghrelin, motilin, leptin and PYY</measure>
    <time_frame>1 week</time_frame>
    <safety_issue>No</safety_issue>
    <description>Blood samples collected to determine hormones via ELISA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IWQOL lite questionnaire</measure>
    <time_frame>1 week</time_frame>
    <safety_issue>No</safety_issue>
    <description>Quality of Life questionnaire  on obesity</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Group 1: Control Group</arm_group_label>
    <description>BMI &lt;30</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>BMI 30-35</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <description>BMI 35-40</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4</arm_group_label>
    <description>BMI &gt;40</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Males and Females undergoing endoscopy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Endoscopic Intervention

        Exclusion Criteria:

          -  18 years of age or older

          -  No acute GI bleeding
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer L Seminerio, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jennifer L Seminerio, MD</last_name>
    <phone>6145624038</phone>
    <email>semineriojl@upmc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Pittsburgh/UPMC Presby</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer L Seminerio, MD</last_name>
      <phone>614-562-4038</phone>
      <email>semineriojl@upmc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 18, 2014</lastchanged_date>
  <firstreceived_date>March 18, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Leptin</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
